An in vivo μPET study confirmed Hsp90-specific tumour binding to B16.F10 melanoma inoculated mice and additionally demonstrated Hsp90-specific binding in blood, lungs and spleen of the tumour-bearing animals (Vermeulen et al. 2019). This evidence concerns the gene HSP90AB1 and neoplasm.